Altium Capital Management LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001746382
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q1 2024 · 69 positions · Total reported value $227.04M · Top-10 concentration 52.2% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 20.0% · 1 new · 3 cut · 0 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -5.1% · vs SPY -7.3% · Prev Value $47.47M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -1.2% · vs SPY -3.4% · Latest Value $68.81M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q1 2024 13F filing, Altium Capital Management LLC disclosed 69 equity positions with a combined reported value of $227.04M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 52.2% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.
The largest disclosed positions as of Q1 2024 were VERA ($30.62M), XENE ($14.98M), AXSM ($11.01M). By sector, the heaviest allocations are Health Care 71.5%, Consumer Discretionary 1.5%. Versus the prior quarter, allocation shifted toward Health Care (+8.9pp), Consumer Discretionary (+1.5pp) and away from Other (-10.2pp).
Versus the prior quarter, Altium Capital Management LLC opened 1 new positions, trimmed 3 and fully exited 0, a turnover rate of 20.0% of positions. The portfolio's overlap with the prior quarter was 46% of names.
The largest new positions opened in Q1 2024 were AVDL ($9.34M), BHVN ($7.66M), VKTX ($6.97M).
Of the 8 positions fully exited versus the prior quarter, the largest were BOXX ($9.75M), IMVT ($3.37M), CBAY ($2.62M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q1 2024)
- AVDL AVADEL PHARMACEUTICALS · $9.34M
- BHVN BIOHAVEN LTD · $7.66M
- VKTX VIKING THERAPEUTICS INC · $6.97M
- CYBN CYBIN INC · $5.77M
- LRMR LARIMAR THERAPEUTICS INC · $5.28M
- MIRM MIRUM PHARMACEUTICALS INC · $5.22M
- PRAX PRAXIS PRECISION MEDICINES I · $4.77M
- ACHV ACHIEVE LIFE SCIENCE INC · $3.80M
Fully Exited (vs previous quarter)
- BOXX EA SERIES TRUST ALPHA ARCH · prev qtr: $9.75M · history
- IMVT IMMUNOVANT INC · prev qtr: $3.37M
- CBAY CYMABAY THERAPEUTICS INC · prev qtr: $2.62M
- SGMT SAGIMET BIOSCIENCES INC · prev qtr: $2.53M
- CRNX CRINETICS PHARMACEUTICALS IN · prev qtr: $2.31M
- NVNO ENVVENO MEDICAL · prev qtr: $1.77M
- AMLX AMYLYX PHARMACEUTICALS INC · prev qtr: $1.76M
- CYTK CYTOKINETICS INC · prev qtr: $1.67M
Insider Transactions (Form 4)
Latest Altium Capital Management LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Altium Capital Management LLC is an SEC-registered 13F filer. As of Q2 2026 it reported 19 US equity positions with a combined value of $47.47M. HoldingsHub carries 11 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 19 positions · $47.47M reported value (Q2 2026)
- Top 10 holdings = 69.3% of reported value
- Largest position: RMT (ROYCE MICRO-CAP TR INC COM) at 8.6%
- Average position size: $2.50M
Sector Tilt
- Financials 91.6%
- Industrials 7.7%
- Health Care 0.7%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 6 added, 1 reduced
- 12 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
710.00K | $30.62M | 13.48% | Add | |
| 2 |
|
348.00K | $14.98M | 6.60% | Add | |
| 3 |
|
138.00K | $11.01M | 4.85% | Hold | |
| 4 |
|
1.54M | $10.16M | 4.48% | Add | |
| 5 |
|
2.55M | $9.95M | 4.38% | Reduce | |
| 6 |
|
553.06K | $9.34M | 4.11% | New | |
| 7 |
|
7.65M | $8.95M | 3.94% | Reduce | |
| 8 |
|
500.00K | $7.97M | 3.51% | Add | |
| 9 |
|
113.00K | $7.82M | 3.44% | Add | |
| 10 |
|
140.00K | $7.66M | 3.37% | New | |
| 11 |
|
85.00K | $6.97M | 3.07% | New | |
| 12 |
|
605.00K | $6.85M | 3.02% | Add | |
| 13 |
|
1.33M | $6.65M | 2.93% | Hold | |
| 14 |
|
152.91K | $6.54M | 2.88% | Add | |
| 15 |
|
13.95M | $5.77M | 2.54% | New | |
| 16 |
|
405.00K | $5.57M | 2.45% | Reduce | |
| 17 |
|
695.00K | $5.28M | 2.32% | New | |
| 18 |
|
208.00K | $5.22M | 2.30% | New | |
| 19 |
|
100.00K | $5.09M | 2.24% | Add | |
| 20 |
|
78.10K | $4.77M | 2.10% | New | |
| 21 |
|
835.47K | $3.80M | 1.67% | New | |
| 22 |
|
25.00K | $3.78M | 1.67% | Hold | |
| 23 |
|
170.00K | $3.67M | 1.62% | New | |
| 24 |
|
120.00K | $3.26M | 1.43% | Hold | |
| 25 |
|
800.00K | $3.13M | 1.38% | New | |
| 26 |
|
77.85K | $3.09M | 1.36% | Reduce | |
| 27 |
|
200.00K | $2.85M | 1.25% | New | |
| 28 |
|
665.00K | $2.83M | 1.25% | New | |
| 29 |
|
57.27K | $2.48M | 1.09% | Add | |
| 30 |
|
1.21M | $2.17M | 0.96% | New | |
| 31 |
|
142.53K | $2.01M | 0.88% | Reduce | |
| 32 |
|
341.46K | $1.98M | 0.87% | New | |
| 33 |
|
200.00K | $1.80M | 0.79% | New | |
| 34 |
|
176.84K | $1.60M | 0.70% | Reduce | |
| 35 |
|
3.01M | $1.59M | 0.70% | New | |
| 36 |
|
65.44K | $1.50M | 0.66% | New | |
| 37 |
|
2.11M | $1.48M | 0.65% | Add | |
| 38 |
|
400.00K | $1.32M | 0.58% | New | |
| 39 |
|
740.00K | $1.12M | 0.49% | Hold | |
| 40 |
|
200.00K | $974.00K | 0.43% | Hold | |
| 41 |
|
1.15M | $903.78K | 0.40% | New | |
| 42 |
|
535.66K | $637.43K | 0.28% | New | |
| 43 |
|
724.94K | $442.21K | 0.20% | New | |
| 44 |
|
92.21K | $330.11K | 0.14% | New | |
| 45 |
|
731.56K | $218.88K | 0.10% | New | |
| 46 |
|
225.00K | $162.00K | 0.07% | Hold | |
| 47 |
|
135.29K | $161.00K | 0.07% | New | |
| 48 |
|
187.98K | $142.87K | 0.06% | New | |
| 49 |
|
1.41M | $109.47K | 0.05% | Hold | |
| 50 |
|
493.15K | $101.34K | 0.04% | New | |
FAQ
What did Altium Capital Management LLC buy in 2024-Q1?
In its 2024-Q1 13F filing, Altium Capital Management LLC reported 69 equity positions worth $227.04M in aggregate; its largest disclosed positions were VERA ($30.62M), XENE ($14.98M), AXSM ($11.01M).
How large is Altium Capital Management LLC's portfolio?
Altium Capital Management LLC reported $227.04M of long equity holdings across 69 positions as of 2024-Q1. Top-10 holdings account for 52.2% of reported value.
What is Altium Capital Management LLC's investment style?
HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.